- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
8th grade Avg
|
- 10-K Annual report
- 10.39 Clinical Research Agreement
- 21 List of Subsidiaries
- 23.1 Consent of Bdo Seidman, LLP
- 23.2 Report of Independent Registered Public Accounting Firm
- 23.3 Consent of Grant Thornton LLP
- 23.4 Report of Independent Registered Public Accounting Firm
- 31.1 Section 302 Cert. - CEO
- 31.2 Section 302 Cert. - CFO
- 32.1 Section 906 Cert. - CEO
- 32.2 Section 906 Cert. - CFO
- 99.3 Financial Statement Schedule
Exhibit 23.2
REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
ON FINANCIAL STATEMENT SCHEDULE
Board of Directors and Shareholders
Mannatech, Incorporated
Coppell, Texas
The audit referred to in our report dated March 14, 2008, relating to the consolidated financial statements of Mannatech, Incorporated and subsidiaries (the Company), which is contained in Item 15(a)(1) of this Form 10-K, also included the audit of the financial statement schedule listed in Item 15(a)(2) of this Form 10-K. The financial statement schedule is the responsibility of the Company’s management. Our responsibility is to express an opinion on this financial statement schedule based on our audit.
In our opinion, such financial statement schedule, when considered in relation to the basic consolidated financial statements taken as a whole, presents fairly, in all material respects, the information set forth therein.
/s/ BDO Seidman, LLP
Dallas, Texas
March 14, 2008